Masimo Current Ratio 2007-2020 | MASI
Current and historical current ratio for Masimo (MASI) from 2007 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending June 30, 2020 was 4.80.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2020-06-30 | $1.09B | $0.23B | 4.80 |
| 2020-03-31 | $0.98B | $0.16B | 6.23 |
| 2019-12-31 | $1.00B | $0.17B | 5.78 |
| 2019-09-30 | $0.93B | $0.15B | 6.23 |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.39 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| 2008-12-31 | $0.23B | $0.07B | 3.54 |
| 2008-09-30 | $0.22B | $0.05B | 4.06 |
| 2008-06-30 | $0.20B | $0.06B | 3.39 |
| 2008-03-31 | $0.17B | $0.06B | 3.18 |
| 2007-12-31 | $0.18B | $0.06B | 2.97 |
| 2007-09-30 | $0.18B | $0.06B | 2.77 |
| 2007-06-30 | $0.12B | $0.07B | 1.78 |
| 2007-03-31 | $0.00B | 0.00 | |
| 2006-09-30 | $0.00B | 0.00 | |
| 2006-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.629B | $0.938B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $162.255B | 30.79 |
| Intuitive Surgical (ISRG) | United States | $79.929B | 71.82 |
| Edwards Lifesciences (EW) | United States | $47.116B | 42.10 |
| DexCom (DXCM) | United States | $40.329B | 139.02 |
| IDEXX Laboratories (IDXX) | United States | $32.082B | 71.30 |
| ALCON INC (ALC) | Switzerland | $29.912B | 33.48 |
| Olympus (OCPNY) | Japan | $26.186B | 68.22 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $25.453B | 16.41 |
| Teleflex (TFX) | United States | $17.509B | 34.53 |
| Hologic (HOLX) | United States | $17.067B | 25.54 |
| Varian Medical Systems (VAR) | United States | $15.741B | 43.33 |
| Sysmex ADR (SSMXY) | Japan | $15.591B | 43.94 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.640B | 0.00 |
| ABIOMED (ABMD) | United States | $13.515B | 80.65 |
| STERIS (STE) | Ireland | $13.258B | 27.25 |
| SARTORIUS AG (SARTF) | Germany | $10.777B | 92.65 |
| Penumbra (PEN) | United States | $8.395B | 1367.59 |
| Tandem Diabetes Care (TNDM) | United States | $6.108B | 0.00 |
| Globus Medical (GMED) | United States | $5.398B | 43.23 |
| Nevro (NVRO) | United States | $4.623B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $4.260B | 32.79 |
| Integra LifeSciences Holdings (IART) | United States | $4.187B | 22.74 |
| Wright Medical Group (WMGI) | Netherlands | $3.902B | 0.00 |
| OPKO Health (OPK) | United States | $3.657B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $3.105B | 31.43 |
| LivaNova (LIVN) | United Kingdom | $2.338B | 23.79 |
| Cantel Medical (CMD) | United States | $2.206B | 25.53 |
| Integer Holdings (ITGR) | United States | $2.129B | 16.13 |
| Glaukos (GKOS) | United States | $1.847B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.641B | 0.00 |
| Veracyte (VCYT) | United States | $1.630B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.622B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.491B | 33.53 |
| Luminex (LMNX) | United States | $1.469B | 137.78 |
| Mesa Laboratories (MLAB) | United States | $1.261B | 62.22 |
| GenMark Diagnostics (GNMK) | United States | $1.099B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.985B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.891B | 0.00 |
| CryoLife (CRY) | United States | $0.810B | 356.67 |
| Tactile Systems Technology (TCMD) | United States | $0.747B | 641.17 |
| Pacific Biosciences Of California (PACB) | United States | $0.727B | 0.00 |
| Inogen (INGN) | United States | $0.716B | 75.44 |
| Intersect ENT (XENT) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.672B | 83.29 |
| Natus Medical (NTUS) | United States | $0.612B | 24.77 |
| Si-Bone (SIBN) | United States | $0.587B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.573B | 0.00 |
| Fluidigm (FLDM) | United States | $0.529B | 0.00 |
| ViewRay (VRAY) | United States | $0.522B | 0.00 |
| AxoGen (AXGN) | United States | $0.466B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.413B | 0.00 |
| Repro Med Systems (KRMD) | United States | $0.413B | 188.20 |
| Vermillion (AWH) | United States | $0.412B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.386B | 0.00 |
| TransMedics (TMDX) | United States | $0.384B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.359B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.351B | 44.96 |
| AngioDynamics (ANGO) | United States | $0.338B | 99.67 |
| Stereotaxis (STXS) | United States | $0.284B | 0.00 |
| IRadimed (IRMD) | United States | $0.266B | 50.58 |
| T2 Biosystems (TTOO) | United States | $0.251B | 0.00 |
| Accuray (ARAY) | United States | $0.238B | 0.00 |
| Sientra (SIEN) | United States | $0.212B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.177B | 0.00 |
| Electromed (ELMD) | United States | $0.157B | 40.17 |
| Restoration Robotics (VERO) | Canada | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.094B | 46.43 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.088B | 0.00 |
| Neuronetics (STIM) | United States | $0.082B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.064B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.060B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.058B | 0.00 |
| ConforMIS (CFMS) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.053B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.052B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.049B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.043B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.040B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.037B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.031B | 0.00 |
| Avinger (AVGR) | United States | $0.030B | 0.00 |
| Neovasc (NVCN) | Canada | $0.026B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.025B | 0.00 |
| TransEnterix (TRXC) | United States | $0.025B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.022B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.021B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.019B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.016B | 0.00 |
| InspireMD (NSPR) | Israel | $0.015B | 0.00 |
| Dynatronics (DYNT) | United States | $0.013B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.012B | 42.80 |
| Viveve Medical (VIVE) | United States | $0.010B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.007B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.006B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.005B | 0.00 |
